A Study to Evaluate Metabolism, Excretion, and Mass Balance of [14C]Vapendavir
Clinical trial NCT06834295 · COMPLETED
Trial details
- NCT number
- NCT06834295
- Sponsor
- Altesa Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-12
- Primary completion
- 2025-03-23
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.